Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
According to our latest study, the global Natamycin market size was valued at USD 191.4 million in 2022 and is forecast to a readjusted size of USD 290.2 million by 2029 with a CAGR of 6.1% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Natamycin key players include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, etc. Global top five players hold a share about 50%.
North America is the largest market, with a share about 35%, followed by Europe and China, having a total share about 35 percent.
In terms of product, the segment includes Glucose-based, Lactose-based, Sodium chloride-based. And in terms of application, the application includes Food Industry, Medical, etc.
This report is a detailed and comprehensive analysis for global Natamycin market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Natamycin market size and forecasts, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Natamycin market size and forecasts by region and country, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Natamycin market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (MT), and average selling prices (USD/MT), 2018-2029
Global Natamycin market shares of main players, shipments in revenue ($ Million), sales quantity (MT), and ASP (USD/MT), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Natamycin
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Natamycin market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Danisco, DSM, VGP, Handary and AMTECH BIOTECH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Natamycin market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Glucose-based
Lactose-based
Sodium chloride-based
Market segment by Application
Food
Medical
Others
Major players covered
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Natamycin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Natamycin, with price, sales, revenue and global market share of Natamycin from 2018 to 2023.
Chapter 3, the Natamycin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Natamycin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Natamycin market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Natamycin.
Chapter 14 and 15, to describe Natamycin sales channel, distributors, customers, research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Natamycin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Natamycin Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Glucose-based
1.3.3 Lactose-based
1.3.4 Sodium chloride-based
1.4 Market Analysis by Application
1.4.1 Overview: Global Natamycin Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Food
1.4.3 Medical
1.4.4 Others
1.5 Global Natamycin Market Size & Forecast
1.5.1 Global Natamycin Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Natamycin Sales Quantity (2018-2029)
1.5.3 Global Natamycin Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Danisco
2.1.1 Danisco Details
2.1.2 Danisco Major Business
2.1.3 Danisco Natamycin Product and Services
2.1.4 Danisco Natamycin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Danisco Recent Developments/Updates
2.2 DSM
2.2.1 DSM Details
2.2.2 DSM Major Business
2.2.3 DSM Natamycin Product and Services
2.2.4 DSM Natamycin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 DSM Recent Developments/Updates
2.3 VGP
2.3.1 VGP Details
2.3.2 VGP Major Business
2.3.3 VGP Natamycin Product and Services
2.3.4 VGP Natamycin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 VGP Recent Developments/Updates
2.4 Handary
2.4.1 Handary Details
2.4.2 Handary Major Business
2.4.3 Handary Natamycin Product and Services
2.4.4 Handary Natamycin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Handary Recent Developments/Updates
2.5 AMTECH BIOTECH
2.5.1 AMTECH BIOTECH Details
2.5.2 AMTECH BIOTECH Major Business
2.5.3 AMTECH BIOTECH Natamycin Product and Services
2.5.4 AMTECH BIOTECH Natamycin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AMTECH BIOTECH Recent Developments/Updates
2.6 Silver-Elephant
2.6.1 Silver-Elephant Details
2.6.2 Silver-Elephant Major Business
2.6.3 Silver-Elephant Natamycin Product and Services
2.6.4 Silver-Elephant Natamycin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Silver-Elephant Recent Developments/Updates
2.7 Lanzhou Weiri
2.7.1 Lanzhou Weiri Details
2.7.2 Lanzhou Weiri Major Business
2.7.3 Lanzhou Weiri Natamycin Product and Services
2.7.4 Lanzhou Weiri Natamycin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Lanzhou Weiri Recent Developments/Updates
2.8 Langfang Meihua
2.8.1 Langfang Meihua Details
2.8.2 Langfang Meihua Major Business
2.8.3 Langfang Meihua Natamycin Product and Services
2.8.4 Langfang Meihua Natamycin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Langfang Meihua Recent Developments/Updates
2.9 Zhengzhou New Frey
2.9.1 Zhengzhou New Frey Details
2.9.2 Zhengzhou New Frey Major Business
2.9.3 Zhengzhou New Frey Natamycin Product and Services
2.9.4 Zhengzhou New Frey Natamycin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Zhengzhou New Frey Recent Developments/Updates
2.10 Chihon
2.10.1 Chihon Details
2.10.2 Chihon Major Business
2.10.3 Chihon Natamycin Product and Services
2.10.4 Chihon Natamycin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Chihon Recent Developments/Updates
2.11 Jiaozuo Joincare
2.11.1 Jiaozuo Joincare Details
2.11.2 Jiaozuo Joincare Major Business
2.11.3 Jiaozuo Joincare Natamycin Product and Services
2.11.4 Jiaozuo Joincare Natamycin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Jiaozuo Joincare Recent Developments/Updates
2.12 Beijing Oriental Rada
2.12.1 Beijing Oriental Rada Details
2.12.2 Beijing Oriental Rada Major Business
2.12.3 Beijing Oriental Rada Natamycin Product and Services
2.12.4 Beijing Oriental Rada Natamycin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Beijing Oriental Rada Recent Developments/Updates
2.13 Pucheng Lifecome
2.13.1 Pucheng Lifecome Details
2.13.2 Pucheng Lifecome Major Business
2.13.3 Pucheng Lifecome Natamycin Product and Services
2.13.4 Pucheng Lifecome Natamycin Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Pucheng Lifecome Recent Developments/Updates
3 Competitive Environment: Natamycin by Manufacturer
3.1 Global Natamycin Sales Quantity by Manufacturer (2018-2023)
3.2 Global Natamycin Revenue by Manufacturer (2018-2023)
3.3 Global Natamycin Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Natamycin by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Natamycin Manufacturer Market Share in 2022
3.4.2 Top 6 Natamycin Manufacturer Market Share in 2022
3.5 Natamycin Market: Overall Company Footprint Analysis
3.5.1 Natamycin Market: Region Footprint
3.5.2 Natamycin Market: Company Product Type Footprint
3.5.3 Natamycin Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Natamycin Market Size by Region
4.1.1 Global Natamycin Sales Quantity by Region (2018-2029)
4.1.2 Global Natamycin Consumption Value by Region (2018-2029)
4.1.3 Global Natamycin Average Price by Region (2018-2029)
4.2 North America Natamycin Consumption Value (2018-2029)
4.3 Europe Natamycin Consumption Value (2018-2029)
4.4 Asia-Pacific Natamycin Consumption Value (2018-2029)
4.5 South America Natamycin Consumption Value (2018-2029)
4.6 Middle East and Africa Natamycin Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Natamycin Sales Quantity by Type (2018-2029)
5.2 Global Natamycin Consumption Value by Type (2018-2029)
5.3 Global Natamycin Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Natamycin Sales Quantity by Application (2018-2029)
6.2 Global Natamycin Consumption Value by Application (2018-2029)
6.3 Global Natamycin Average Price by Application (2018-2029)
7 North America
7.1 North America Natamycin Sales Quantity by Type (2018-2029)
7.2 North America Natamycin Sales Quantity by Application (2018-2029)
7.3 North America Natamycin Market Size by Country
7.3.1 North America Natamycin Sales Quantity by Country (2018-2029)
7.3.2 North America Natamycin Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Natamycin Sales Quantity by Type (2018-2029)
8.2 Europe Natamycin Sales Quantity by Application (2018-2029)
8.3 Europe Natamycin Market Size by Country
8.3.1 Europe Natamycin Sales Quantity by Country (2018-2029)
8.3.2 Europe Natamycin Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Natamycin Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Natamycin Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Natamycin Market Size by Region
9.3.1 Asia-Pacific Natamycin Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Natamycin Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Natamycin Sales Quantity by Type (2018-2029)
10.2 South America Natamycin Sales Quantity by Application (2018-2029)
10.3 South America Natamycin Market Size by Country
10.3.1 South America Natamycin Sales Quantity by Country (2018-2029)
10.3.2 South America Natamycin Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Natamycin Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Natamycin Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Natamycin Market Size by Country
11.3.1 Middle East & Africa Natamycin Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Natamycin Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Natamycin Market Drivers
12.2 Natamycin Market Restraints
12.3 Natamycin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Natamycin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Natamycin
13.3 Natamycin Production Process
13.4 Natamycin Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Natamycin Typical Distributors
14.3 Natamycin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
List of Tables
Table 1. Global Natamycin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Natamycin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Danisco Basic Information, Manufacturing Base and Competitors
Table 4. Danisco Major Business
Table 5. Danisco Natamycin Product and Services
Table 6. Danisco Natamycin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Danisco Recent Developments/Updates
Table 8. DSM Basic Information, Manufacturing Base and Competitors
Table 9. DSM Major Business
Table 10. DSM Natamycin Product and Services
Table 11. DSM Natamycin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. DSM Recent Developments/Updates
Table 13. VGP Basic Information, Manufacturing Base and Competitors
Table 14. VGP Major Business
Table 15. VGP Natamycin Product and Services
Table 16. VGP Natamycin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. VGP Recent Developments/Updates
Table 18. Handary Basic Information, Manufacturing Base and Competitors
Table 19. Handary Major Business
Table 20. Handary Natamycin Product and Services
Table 21. Handary Natamycin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Handary Recent Developments/Updates
Table 23. AMTECH BIOTECH Basic Information, Manufacturing Base and Competitors
Table 24. AMTECH BIOTECH Major Business
Table 25. AMTECH BIOTECH Natamycin Product and Services
Table 26. AMTECH BIOTECH Natamycin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AMTECH BIOTECH Recent Developments/Updates
Table 28. Silver-Elephant Basic Information, Manufacturing Base and Competitors
Table 29. Silver-Elephant Major Business
Table 30. Silver-Elephant Natamycin Product and Services
Table 31. Silver-Elephant Natamycin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Silver-Elephant Recent Developments/Updates
Table 33. Lanzhou Weiri Basic Information, Manufacturing Base and Competitors
Table 34. Lanzhou Weiri Major Business
Table 35. Lanzhou Weiri Natamycin Product and Services
Table 36. Lanzhou Weiri Natamycin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Lanzhou Weiri Recent Developments/Updates
Table 38. Langfang Meihua Basic Information, Manufacturing Base and Competitors
Table 39. Langfang Meihua Major Business
Table 40. Langfang Meihua Natamycin Product and Services
Table 41. Langfang Meihua Natamycin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Langfang Meihua Recent Developments/Updates
Table 43. Zhengzhou New Frey Basic Information, Manufacturing Base and Competitors
Table 44. Zhengzhou New Frey Major Business
Table 45. Zhengzhou New Frey Natamycin Product and Services
Table 46. Zhengzhou New Frey Natamycin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Zhengzhou New Frey Recent Developments/Updates
Table 48. Chihon Basic Information, Manufacturing Base and Competitors
Table 49. Chihon Major Business
Table 50. Chihon Natamycin Product and Services
Table 51. Chihon Natamycin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Chihon Recent Developments/Updates
Table 53. Jiaozuo Joincare Basic Information, Manufacturing Base and Competitors
Table 54. Jiaozuo Joincare Major Business
Table 55. Jiaozuo Joincare Natamycin Product and Services
Table 56. Jiaozuo Joincare Natamycin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Jiaozuo Joincare Recent Developments/Updates
Table 58. Beijing Oriental Rada Basic Information, Manufacturing Base and Competitors
Table 59. Beijing Oriental Rada Major Business
Table 60. Beijing Oriental Rada Natamycin Product and Services
Table 61. Beijing Oriental Rada Natamycin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Beijing Oriental Rada Recent Developments/Updates
Table 63. Pucheng Lifecome Basic Information, Manufacturing Base and Competitors
Table 64. Pucheng Lifecome Major Business
Table 65. Pucheng Lifecome Natamycin Product and Services
Table 66. Pucheng Lifecome Natamycin Sales Quantity (MT), Average Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Pucheng Lifecome Recent Developments/Updates
Table 68. Global Natamycin Sales Quantity by Manufacturer (2018-2023) & (MT)
Table 69. Global Natamycin Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Natamycin Average Price by Manufacturer (2018-2023) & (USD/MT)
Table 71. Market Position of Manufacturers in Natamycin, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Natamycin Production Site of Key Manufacturer
Table 73. Natamycin Market: Company Product Type Footprint
Table 74. Natamycin Market: Company Product Application Footprint
Table 75. Natamycin New Market Entrants and Barriers to Market Entry
Table 76. Natamycin Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Natamycin Sales Quantity by Region (2018-2023) & (MT)
Table 78. Global Natamycin Sales Quantity by Region (2024-2029) & (MT)
Table 79. Global Natamycin Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Natamycin Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Natamycin Average Price by Region (2018-2023) & (USD/MT)
Table 82. Global Natamycin Average Price by Region (2024-2029) & (USD/MT)
Table 83. Global Natamycin Sales Quantity by Type (2018-2023) & (MT)
Table 84. Global Natamycin Sales Quantity by Type (2024-2029) & (MT)
Table 85. Global Natamycin Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Natamycin Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Natamycin Average Price by Type (2018-2023) & (USD/MT)
Table 88. Global Natamycin Average Price by Type (2024-2029) & (USD/MT)
Table 89. Global Natamycin Sales Quantity by Application (2018-2023) & (MT)
Table 90. Global Natamycin Sales Quantity by Application (2024-2029) & (MT)
Table 91. Global Natamycin Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Natamycin Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Natamycin Average Price by Application (2018-2023) & (USD/MT)
Table 94. Global Natamycin Average Price by Application (2024-2029) & (USD/MT)
Table 95. North America Natamycin Sales Quantity by Type (2018-2023) & (MT)
Table 96. North America Natamycin Sales Quantity by Type (2024-2029) & (MT)
Table 97. North America Natamycin Sales Quantity by Application (2018-2023) & (MT)
Table 98. North America Natamycin Sales Quantity by Application (2024-2029) & (MT)
Table 99. North America Natamycin Sales Quantity by Country (2018-2023) & (MT)
Table 100. North America Natamycin Sales Quantity by Country (2024-2029) & (MT)
Table 101. North America Natamycin Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Natamycin Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Natamycin Sales Quantity by Type (2018-2023) & (MT)
Table 104. Europe Natamycin Sales Quantity by Type (2024-2029) & (MT)
Table 105. Europe Natamycin Sales Quantity by Application (2018-2023) & (MT)
Table 106. Europe Natamycin Sales Quantity by Application (2024-2029) & (MT)
Table 107. Europe Natamycin Sales Quantity by Country (2018-2023) & (MT)
Table 108. Europe Natamycin Sales Quantity by Country (2024-2029) & (MT)
Table 109. Europe Natamycin Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Natamycin Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Natamycin Sales Quantity by Type (2018-2023) & (MT)
Table 112. Asia-Pacific Natamycin Sales Quantity by Type (2024-2029) & (MT)
Table 113. Asia-Pacific Natamycin Sales Quantity by Application (2018-2023) & (MT)
Table 114. Asia-Pacific Natamycin Sales Quantity by Application (2024-2029) & (MT)
Table 115. Asia-Pacific Natamycin Sales Quantity by Region (2018-2023) & (MT)
Table 116. Asia-Pacific Natamycin Sales Quantity by Region (2024-2029) & (MT)
Table 117. Asia-Pacific Natamycin Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Natamycin Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Natamycin Sales Quantity by Type (2018-2023) & (MT)
Table 120. South America Natamycin Sales Quantity by Type (2024-2029) & (MT)
Table 121. South America Natamycin Sales Quantity by Application (2018-2023) & (MT)
Table 122. South America Natamycin Sales Quantity by Application (2024-2029) & (MT)
Table 123. South America Natamycin Sales Quantity by Country (2018-2023) & (MT)
Table 124. South America Natamycin Sales Quantity by Country (2024-2029) & (MT)
Table 125. South America Natamycin Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Natamycin Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Natamycin Sales Quantity by Type (2018-2023) & (MT)
Table 128. Middle East & Africa Natamycin Sales Quantity by Type (2024-2029) & (MT)
Table 129. Middle East & Africa Natamycin Sales Quantity by Application (2018-2023) & (MT)
Table 130. Middle East & Africa Natamycin Sales Quantity by Application (2024-2029) & (MT)
Table 131. Middle East & Africa Natamycin Sales Quantity by Region (2018-2023) & (MT)
Table 132. Middle East & Africa Natamycin Sales Quantity by Region (2024-2029) & (MT)
Table 133. Middle East & Africa Natamycin Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Natamycin Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Natamycin Raw Material
Table 136. Key Manufacturers of Natamycin Raw Materials
Table 137. Natamycin Typical Distributors
Table 138. Natamycin Typical Customers
List of Figures
Figure 1. Natamycin Picture
Figure 2. Global Natamycin Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Natamycin Consumption Value Market Share by Type in 2022
Figure 4. Glucose-based Examples
Figure 5. Lactose-based Examples
Figure 6. Sodium chloride-based Examples
Figure 7. Global Natamycin Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Natamycin Consumption Value Market Share by Application in 2022
Figure 9. Food Examples
Figure 10. Medical Examples
Figure 11. Others Examples
Figure 12. Global Natamycin Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Natamycin Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Natamycin Sales Quantity (2018-2029) & (MT)
Figure 15. Global Natamycin Average Price (2018-2029) & (USD/MT)
Figure 16. Global Natamycin Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Natamycin Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Natamycin by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Natamycin Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Natamycin Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Natamycin Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Natamycin Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Natamycin Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Natamycin Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Natamycin Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Natamycin Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Natamycin Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Natamycin Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Natamycin Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Natamycin Average Price by Type (2018-2029) & (USD/MT)
Figure 31. Global Natamycin Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Natamycin Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Natamycin Average Price by Application (2018-2029) & (USD/MT)
Figure 34. North America Natamycin Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Natamycin Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Natamycin Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Natamycin Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Natamycin Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Natamycin Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Natamycin Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Natamycin Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Natamycin Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Natamycin Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Natamycin Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Natamycin Consumption Value Market Share by Region (2018-2029)
Figure 54. China Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Natamycin Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Natamycin Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Natamycin Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Natamycin Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Natamycin Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Natamycin Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Natamycin Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Natamycin Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Natamycin Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Natamycin Market Drivers
Figure 75. Natamycin Market Restraints
Figure 76. Natamycin Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Natamycin in 2022
Figure 79. Manufacturing Process Analysis of Natamycin
Figure 80. Natamycin Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source